These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7779345)

  • 1. Psychotropic drugs in group homes: prevalence and relation to demographic/psychiatric variables.
    Aman MG; Sarphare G; Burrow WH
    Am J Ment Retard; 1995 Mar; 99(5):500-9. PubMed ID: 7779345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of psychoactive drug use among North Dakota group home residents.
    Burd L; Fisher W; Vesely BN; Williams M; Kerbeshian J; Leech C
    Am J Ment Retard; 1991 Sep; 96(2):119-26. PubMed ID: 1930945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine.
    Friedman DL; Kastner T; Plummer AT; Ruiz MQ; Henning D
    Am J Ment Retard; 1992 Mar; 96(5):541-6. PubMed ID: 1562312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic drug use in intellectually disabled group-home residents with behavioural problems.
    Stolker JJ; Koedoot PJ; Heerdink ER; Leufkens HG; Nolen WA
    Pharmacopsychiatry; 2002 Jan; 35(1):19-23. PubMed ID: 11819154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral problems and medication utilization.
    Harper DC; Wadsworth JS
    Ment Retard; 1993 Apr; 31(2):97-103. PubMed ID: 8479337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic medication in adults with mental retardation: prevalence, and prescription practices.
    Holden B; Gitlesen JP
    Res Dev Disabil; 2004; 25(6):509-21. PubMed ID: 15541629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication and programming in controlling the behavior of mentally retarded individuals in community settings.
    Schalock RL; Foley JW; Toulouse A; Stark JA
    Am J Ment Defic; 1985 Mar; 89(5):503-9. PubMed ID: 2859807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use.
    Aman MG; Van Bourgondien ME; Wolford PL; Sarphare G
    J Am Acad Child Adolesc Psychiatry; 1995 Dec; 34(12):1672-81. PubMed ID: 8543539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
    Madrid AL; State MW; King BH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [How should mentally handicapped adults with depressive disorders be treated psychopharmacologically?].
    Meins W
    Nervenarzt; 1996 Mar; 67(3):216-8. PubMed ID: 8901279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia.
    Chibnall JT; Tait RC; Harman B; Luebbert RA
    J Am Geriatr Soc; 2005 Nov; 53(11):1921-9. PubMed ID: 16274373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic medication of mentally retarded residents in community long-term care facilities.
    Buck JA; Sprague RL
    Am J Ment Retard; 1989 May; 93(6):618-23. PubMed ID: 2566316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a functional analysis of drug treatment for behavior problems of people with developmental disabilities.
    Schaal DW; Hackenberg T
    Am J Ment Retard; 1994 Sep; 99(2):123-40. PubMed ID: 7803030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes--a 12-month follow-up study.
    Selbaek G; Kirkevold Ø; Engedal K
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):528-36. PubMed ID: 18591573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
    Curran S; Turner D; Musa S; Wattis J
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative survey of drug use in a community service system.
    Zaharia ES; Struxness L
    Ment Retard; 1991 Aug; 29(4):191-4. PubMed ID: 1921727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation.
    de Bildt A; Mulder EJ; Scheers T; Minderaa RB; Tobi H
    Pediatrics; 2006 Dec; 118(6):e1860-6. PubMed ID: 17142506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of psychotropic medication among individuals with mental retardation].
    Baasland G; Engedal K
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1751-3. PubMed ID: 19756056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of psychotropic medication in Oklahoma: a statewide survey.
    Spreat S; Conroy JW; Jones JC
    Am J Ment Retard; 1997 Jul; 102(1):80-5. PubMed ID: 9241410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.